Not another ChatGPT wrapper. ValOracle is a vertically integrated AI platform engineered specifically for pharmaceutical market access strategy.
4 units: 1 operational, 3 deploying. 192GB RAM per unit. Local inference runs at full capacity without cloud dependency.
Nemotron 120B Super and Qwen 3.5-35B run on-premises. Your data never touches a third-party cloud.
Continuous batching for high-throughput model serving. Optimized request scheduling and KV cache management.
400 Gbps interconnect between nodes. Sub-millisecond latency for distributed compute coordination.
Your data never touches a third-party cloud. Every model runs on our own hardware. No data leakage. No training on your inputs. Period.
Multi-step workflows with state management, conditional branching, and parallel execution. 45 workflows across 8 market access domains.
Not all problems require frontier models. We use specialist models for what they do best:
Data retrieval, evidence synthesis, routine analysis. Fast, private, deterministic.
Deep strategic reasoning, scenario analysis, high-judgment calls. Only when it matters.
Structured knowledge graphs + vector embeddings. Two retrieval modes working in concert:
3 specialized adapters in development:
Scenario analysis, counterfactual reasoning, competitive positioning.
Evidence synthesis, systematic review integration, meta-analysis.
Executive prose, institutional tone, board-ready presentations.
Real-time trial data. Competitor pipeline monitoring. Phase progression tracking.
Approval history, label updates, regulatory precedents, breakthrough designations.
Drug pricing data, reimbursement rates, competitive pricing benchmarks.
NCD/LCD policies, coverage determination logic, appeals pathways.
Biomedical literature, systematic reviews, health economics data.
Payer coverage status, tier placement, utilization management rules.
Real data, real-time. Not a language model hallucinating pricing numbers or trial enrollment data. Every figure is retrievable, traceable, and auditable.
Every output is reviewed by a panel of 4-6 AI personas before delivery. This is the same adversarial pressure-testing that happens in a real P&T committee—built into every assessment.
Modeled on real-world decision-makers in market access:
Clinical efficacy, safety profile, comparative value. Asks: "Is this truly better?"
Methodological rigor, evidence quality, incremental cost-effectiveness. Asks: "What's the ICER?"
Budget impact, cost-offsets, societal ROI. Asks: "Do the numbers hold?"
Launch strategy, payer sequencing, contracting leverage. Asks: "Is this winnable?"
Drug interactions, patient populations, usage patterns. Asks: "Will patients actually use this?"
Each persona produces structured feedback: strengths, gaps, concerns, recommendations. Feedback loops back into the analysis pipeline for revision. The output you receive is consensus across all reviewers.
All inference on-premises. No client data sent to third-party APIs for model training.
Cross-reference traceability. Every recommendation traces back to: Evidence → Need → Gap → Action.
Security controls, access management, incident response. Path to certification mapped.
No PHI in training data. Encryption at rest and in transit. Role-based access controls.
Choose the level of human oversight that matches your use case:
| Tier | Human Role | Workflow | Best For |
|---|---|---|---|
| Self-ServiceFull AI execution + synthetic panel review | User defines parameters, reviews output | ValOracle executes analysis autonomously. Synthetic experts review. You sign off. | Rapid landscape scans, continuous monitoring, internal briefings |
| GuidedCore AI analysis with human checkpoints | Expert reviews key outputs at defined gates | AI gathers data & synthesis. Your expert reviews methodology, findings, recommendations. AI refines. | Strategic assessments for board-level decisions |
| PremiumAI analysis + senior strategist overlay | Senior strategist provides overlay, presentation, consultation | AI handles data + synthesis. Your strategist provides institutional judgment, final shape, stakeholder briefing. | High-stakes launch strategies, investor materials, C-suite presentations |
| Dimension | ChatGPT / Generic AI | ValOracle |
|---|---|---|
| Domain Knowledge | General training data | Purpose-built for market access |
| Data Sources | Training cutoff only | Real-time API integration (FDA, CMS, ClinicalTrials.gov) |
| Quality Assurance | None | Synthetic expert panel review (4-6 personas) |
| Deliverables | Chat responses | Institutional-quality PPTX/DOCX with cross-references |
| Traceability | None | Full ED→NEED→GAP→ACT audit trail |
| Data Privacy | Data may be used for training | Zero data leakage, on-premises inference |
| Workflows | Single prompt | 45 multi-step orchestrated workflows |
Request a demo and watch ValOracle analyze a market access challenge in real-time.
Request Demo